S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q4 2023

RA Capital Management

Period: Q4 2023 Β· Filed: 2024-02-14
View on SEC EDGAR β†—
AUM
$6.40B
Total portfolio value
Positions
62
Reported securities
Top Holding
ASND
19.9% $1.27B
QoQ Changes
+6 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S - ADR$1.27B19.88%$127.53$274.50+115.2%
19.9%
IMGNIMMUNOGEN INC$704.2M11.00%β€”β€”
11.0%
PCVXVAXCYTE INC$495.6M7.74%$62.94$58.39-7.2%
7.7%
LEGNLEGEND BIOTECH CORP-ADR$376.9M5.89%$59.10$29.91-49.4%
5.9%
RYTMRHYTHM PHARMACEUTICALS INC$245.0M3.83%$45.13$114.17+153.0%
3.8%
AVTEAEROVATE THERAPEUTICS INC$187.0M2.92%β€”β€”
2.9%
INBXINHIBRX INC$179.5M2.80%β€”$97.58
2.8%
CBAYCYMABAY THERAPEUTICS INC$163.9M2.56%β€”β€”
2.6%
BIIBBIOGEN INC$137.9M2.15%$267.71$216.12-19.3%
2.1%
RXSTRXSIGHT INC$137.3M2.14%$36.65$5.61-84.7%
2.1%
ETNB89BIO INC$127.5M1.99%β€”β€”
2.0%
VRNAVERONA PHARMA PLC - ADR$125.6M1.96%β€”β€”
2.0%
DAWNDAY ONE BIOPHARMACEUTICALS I$114.0M1.78%β€”β€”
1.8%
ANTXAN2 THERAPEUTICS INC$113.8M1.78%$19.87$4.42-77.8%
1.8%
TYRATYRA BIOSCIENCES INC$100.2M1.57%$14.04$30.62+118.1%
1.6%
JANXJANUX THERAPEUTICS INC$98.3M1.54%$11.02$15.54+41.0%
1.5%
GERNGERON CORP$97.5M1.52%$2.14$1.36-36.5%
1.5%
ICVXICOSAVAX INC$94.0M1.47%β€”β€”
1.5%
ALPNALPINE IMMUNE SCIENCES INC$93.6M1.46%β€”β€”
1.5%
WVEWAVE LIFE SCIENCES LTD$91.9M1.44%$5.34$6.26+17.2%
1.4%
NAMSNEWAMSTERDAM PHARMA CO NV$87.8M1.37%$11.95$34.83+191.5%
1.4%
FDMT4D MOLECULAR THERAPEUTICS IN$84.3M1.32%$21.25$13.00-38.8%
1.3%
EVHEVOLENT HEALTH INC - A$84.2M1.32%$33.28$5.71-82.8%
1.3%
AXSMAXSOME THERAPEUTICS INC$79.6M1.24%$77.06$244.31+217.0%
1.2%
FULCFULCRUM THERAPEUTICS INC$78.4M1.22%$7.21$3.84-46.7%
1.2%
CTKBCYTEK BIOSCIENCES INC$62.1M0.97%$8.87$4.59-48.3%
1.0%
ABOSACUMEN PHARMACEUTICALS INC$57.3M0.90%$4.23$2.74-35.2%
0.9%
PEPGPEPGEN INC$55.3M0.86%$7.09$1.76-75.2%
0.9%
APGEAPOGEE THERAPEUTICS INC$55.3M0.86%$28.51$132.91+366.2%
0.9%
SPRYARS PHARMACEUTICALS INC$51.8M0.81%$5.58$8.56+53.4%
0.8%

Quarter-on-Quarter Activity

Q4 2023 vs. Q3 2023

New Positions (6)

TickerIssuerNotionalSince Filing
CTKBCYTEK BIOSCIENCES INC$62.1M-48.3%
CCCCC4 THERAPEUTICS INC$27.6M
GPCRSTRUCTURE THERAPEUTICS INC$19.8M
ARVNARVINAS INC$17.3M
HARPHARPOON THERAPEUTICS INC$17.1M
SABSSAB BIOTHERAPEUTICS INC$1.6M

Exited Positions (8)

TickerIssuerNotional
COGTCOGENT BIOSCIENCES INC$62.6M
SLNOSOLENO THERAPEUTICS INC$36.6M
VRDNVIRIDIAN THERAPEUTICS INC$30.8M
ACRSACLARIS THERAPEUTICS INC$30.1M
EYPTEYEPOINT PHARMACEUTICALS INC$26.9M
CELCCELCUITY INC$12.8M
NKTRNEKTAR THERAPEUTICS$11.1M
TALSTALARIS THERAPEUTICS INC$6.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
MGNXMACROGENICS INC$37.4M+1085.1%
THRDTHIRD HARMONIC BIO INC$16.2M+111.4%
URGNUROGEN PHARMA LTD$25.5M+107.8%
IMGNIMMUNOGEN INC$492.8M+78.3%
CMRXCHIMERIX INC$2.2M+35.4%
RXSTRXSIGHT INC$52.1M+11.5%-84.7%
WVEWAVE LIFE SCIENCES LTD$-7.0M+5.8%+17.2%
ALPNALPINE IMMUNE SCIENCES INC$39.9M+4.7%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
CVACCUREVAC NV$-60.9M-74.1%
RNAMAVIDITY BIOSCIENCES INC$-18.7M-61.7%
CNTBXXXXCONNECT BIOPHARMA HOLDINGS L$-2.1M-56.2%
PLRXPLIANT THERAPEUTICS INC$-7.3M-27.3%
TNYATENAYA THERAPEUTICS INC$0.7M-18.0%
NAMSNEWAMSTERDAM PHARMA CO NV$4.6M-12.6%+191.5%
EVHEVOLENT HEALTH INC - A$9.7M-6.9%-82.8%
RYTMRHYTHM PHARMACEUTICALS INC$114.9M-6.1%+153.0%
← Back to Hedge Funds